🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/03/2009 | 25,74 | 26,18 | 24,92 | 25,01 | -3,18% | 4,89% | 34.252.203 |
| 13/03/2009 | 23,15 | 26,43 | 23,15 | 25,83 | +12,65% | 14,18% | 60.001.249 |
| 12/03/2009 | 20,86 | 22,99 | 20,67 | 22,93 | +9,53% | 11,12% | 40.235.864 |
| 11/03/2009 | 21,13 | 21,69 | 20,80 | 20,94 | -1,17% | 4,20% | 29.498.685 |
| 10/03/2009 | 20,64 | 21,29 | 20,41 | 21,18 | +5,76% | 4,25% | 36.396.411 |
| 09/03/2009 | 19,23 | 21,47 | 19,13 | 20,03 | -7,70% | 12,16% | 88.189.724 |
| 06/03/2009 | 21,33 | 21,89 | 21,03 | 21,70 | +2,71% | 4,03% | 18.906.130 |
| 05/03/2009 | 21,56 | 21,84 | 20,93 | 21,13 | -4,45% | 4,25% | 21.628.205 |
| 04/03/2009 | 22,15 | 22,45 | 21,41 | 22,11 | +0,52% | 4,70% | 22.605.674 |
| 03/03/2009 | 22,60 | 23,00 | 21,81 | 21,99 | -1,66% | 5,24% | 18.975.402 |
| 02/03/2009 | 22,73 | 23,21 | 22,35 | 22,37 | -3,14% | 3,78% | 17.418.808 |
| 27/02/2009 | 24,30 | 24,60 | 23,06 | 23,09 | -7,07% | 6,32% | 34.071.738 |
| 26/02/2009 | 26,88 | 26,88 | 24,84 | 24,85 | -6,70% | 7,60% | 20.846.816 |
| 25/02/2009 | 26,90 | 27,15 | 26,45 | 26,63 | -2,17% | 2,59% | 22.865.054 |
| 24/02/2009 | 26,63 | 27,25 | 26,28 | 27,22 | +2,33% | 3,65% | 18.588.586 |
| 23/02/2009 | 26,36 | 27,09 | 26,36 | 26,60 | -0,78% | 2,79% | 18.829.730 |
| 20/02/2009 | 26,81 | 27,21 | 26,52 | 26,81 | -1,51% | 2,60% | 18.552.639 |
| 19/02/2009 | 27,61 | 27,67 | 27,16 | 27,22 | -0,38% | 1,87% | 10.332.651 |
| 18/02/2009 | 27,40 | 27,48 | 26,72 | 27,33 | +0,10% | 2,79% | 15.041.210 |
| 17/02/2009 | 26,85 | 27,70 | 26,60 | 27,30 | -0,49% | 4,09% | 21.584.922 |
| 13/02/2009 | 27,93 | 28,05 | 27,21 | 27,43 | -2,01% | 3,01% | 11.000.751 |
| 12/02/2009 | 27,89 | 28,08 | 27,22 | 28,00 | -1,28% | 3,08% | 11.389.769 |
| 11/02/2009 | 27,77 | 28,57 | 27,68 | 28,36 | +2,45% | 3,20% | 10.812.321 |
| 10/02/2009 | 29,07 | 29,25 | 27,54 | 27,68 | -5,35% | 5,87% | 15.057.140 |
| 09/02/2009 | 29,26 | 29,46 | 28,79 | 29,25 | -0,39% | 2,28% | 9.146.839 |
| 06/02/2009 | 28,64 | 29,51 | 28,64 | 29,36 | +2,23% | 3,07% | 11.599.788 |
| 05/02/2009 | 27,29 | 29,06 | 27,29 | 28,72 | +0,67% | 6,50% | 14.368.499 |
| 04/02/2009 | 28,86 | 29,45 | 28,24 | 28,53 | -1,12% | 4,17% | 13.599.372 |
| 03/02/2009 | 28,51 | 29,35 | 27,61 | 28,86 | +6,37% | 6,12% | 24.482.538 |
| 02/02/2009 | 26,80 | 27,61 | 26,72 | 27,13 | -0,42% | 3,35% | 14.703.021 |